BridgeMD
New treatment option for Chronic Subdural Hematoma
Official title Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma
ClinicalTrials.gov ID: NCT07240454
What this study is testing
What is Aspirin Continuation?
Aspirin Continuation is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for chronic subdural hematoma.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This clinical study aims to learn about the efficacy and safety of aspirin continuation or discontinuation in conservative treatment for chronic subdural hematoma. All participants received standard conservative treatment for chronic subdural hematoma, with a randomized intervention to either continue or discontinue aspirin administration.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years, male or female;
- Confirmed diagnosis of chronic subdural hematoma (cSDH) by cranial CT and/or MRI;
- Intended for conservative management (i.e., no surgical evacuation indication at enrollment);
- Regular aspirin use at enrollment;
- Informed consent signed by the patient or legal representative.
You likely can't join if
- Patients requiring emergency surgery to remove hematoma at enrollment;
- Concurrent use of other anticoagulants or antiplatelet agents that cannot be discontinued according to the study protocol;
- cSDH secondary to other diseases or conditions (e.g., excessive drainage from ventriculoperitoneal shunts, intracranial tumors);
- Active bleeding events or major cardiac events (e.g., acute myocardial infarction, unstable angina, or revascularization surgery) within 30 days...
- Known bleeding disorders (e.g., hemophilia, severe thrombocytopenia);
- Individuals unable to provide informed consent or for whom completion of follow-up is anticipated to be difficult.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
- Tianjin, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China; Tianjin, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.